Fundraising Fox
Axion BioSystems
Atlanta, US · Delaware corporation · 127 employees on LinkedIn · 1 known investors
Find your way into Axion BioSystems
Sign up to see every warm intro you have to Axion BioSystems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Axion BioSystems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 1
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$14.3M disclosed across 2 rounds · 2016–2018
▶$8MraisedOct 2018 · 31 investors · BiotechnologyRule 506(b)
- JAMES ROSSExecutive Officer, Director
- JAY TEICHDirector
- DAVID GIBSONDirector
- THOMAS J. O'BRIENExecutive Officer, Director
- MICHELLE JARRARDDirector
- GLENN EPSTEINDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MraisedMay 2016 · 16 investors · BiotechnologyRule 506(b)
- THOMAS J. O'BRIENExecutive Officer, Director
- GLENN EPSTEINDirector
- DAVID GIBSONDirector
- JAMES ROSSExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $6.3M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Axion BioSystems went on to found or lead other companies.
Acquisitions · 1
Early investors' stakes continue via these dealsCytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system. It serves cell biologists working in therapeutic areas such as vascular biology, stem cell differentiation, cardiovascular and neurological disease, and oncology.
Frequently asked questions
- Who founded Axion BioSystems?
- Axion BioSystems was founded by JAMES ROSS.
- Who are Axion BioSystems's investors?
- Axion BioSystems's investors include McKinsey & Company.
- How much funding has Axion BioSystems raised?
- Axion BioSystems has disclosed $14.3M raised across 2 rounds.
- Where is Axion BioSystems headquartered?
- Axion BioSystems is headquartered in Atlanta, US.